When Hypereosinophilia Leads to Stroke

AFIP1L1-PDGFRA fusion can only be confirmed through molecular and cytogenetic investigations causing a delay in the diagnosis. However, patients with this mutation need urgent treatment because they present hypereosinophilia which may be associated with short-term tissue damage. Thromboembolism is a...

Full description

Bibliographic Details
Main Authors: Emilie Chalayer, Aude Pelissier, Bernard Tardy
Format: Article
Language:English
Published: SMC MEDIA SRL 2017-04-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:http://ejcrim.com/index.php/EJCRIM/article/view/614
_version_ 1819142304671203328
author Emilie Chalayer
Aude Pelissier
Bernard Tardy
author_facet Emilie Chalayer
Aude Pelissier
Bernard Tardy
author_sort Emilie Chalayer
collection DOAJ
description AFIP1L1-PDGFRA fusion can only be confirmed through molecular and cytogenetic investigations causing a delay in the diagnosis. However, patients with this mutation need urgent treatment because they present hypereosinophilia which may be associated with short-term tissue damage. Thromboembolism is a known cause of death in hypereosinophilic syndrome. A case of Loeffler endocarditis due to FIP1L1-PDGFRA-associated chronic eosinophilic leukemia presenting hemiparesis with fever, which also mislead the initial diagnosis, is reported.
first_indexed 2024-12-22T12:08:13Z
format Article
id doaj.art-18c7c49e4040411fa7ccaa8c86290b1e
institution Directory Open Access Journal
issn 2284-2594
language English
last_indexed 2024-12-22T12:08:13Z
publishDate 2017-04-01
publisher SMC MEDIA SRL
record_format Article
series European Journal of Case Reports in Internal Medicine
spelling doaj.art-18c7c49e4040411fa7ccaa8c86290b1e2022-12-21T18:26:22ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942017-04-012010.12890/2017_000614218When Hypereosinophilia Leads to StrokeEmilie Chalayer0Aude Pelissier1Bernard Tardy2Intensive care unit, CHU Saint Etienne, Hopital Nord, 42055 Saint EtienneIntensive care unit, CHU Saint Etienne, Hopital Nord, 42055 Saint EtienneClinical Investigation Center - CIC 1408, CHU Saint Etienne, FranceAFIP1L1-PDGFRA fusion can only be confirmed through molecular and cytogenetic investigations causing a delay in the diagnosis. However, patients with this mutation need urgent treatment because they present hypereosinophilia which may be associated with short-term tissue damage. Thromboembolism is a known cause of death in hypereosinophilic syndrome. A case of Loeffler endocarditis due to FIP1L1-PDGFRA-associated chronic eosinophilic leukemia presenting hemiparesis with fever, which also mislead the initial diagnosis, is reported.http://ejcrim.com/index.php/EJCRIM/article/view/614Hypereosinophilia, stroke, cytomegalovirus, Loeffer endocarditis
spellingShingle Emilie Chalayer
Aude Pelissier
Bernard Tardy
When Hypereosinophilia Leads to Stroke
European Journal of Case Reports in Internal Medicine
Hypereosinophilia, stroke, cytomegalovirus, Loeffer endocarditis
title When Hypereosinophilia Leads to Stroke
title_full When Hypereosinophilia Leads to Stroke
title_fullStr When Hypereosinophilia Leads to Stroke
title_full_unstemmed When Hypereosinophilia Leads to Stroke
title_short When Hypereosinophilia Leads to Stroke
title_sort when hypereosinophilia leads to stroke
topic Hypereosinophilia, stroke, cytomegalovirus, Loeffer endocarditis
url http://ejcrim.com/index.php/EJCRIM/article/view/614
work_keys_str_mv AT emiliechalayer whenhypereosinophilialeadstostroke
AT audepelissier whenhypereosinophilialeadstostroke
AT bernardtardy whenhypereosinophilialeadstostroke